Antiretroviral Therapy–Induced Bone Loss Is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-Naive Persons with Human Immunodeficiency Virus Infection: A Phase IIB Trial

相似書籍

• A Single-dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy–induced Bone Loss in Treatment-naive HIV-infected Patients: A Phase IIb Trial
  由: Ofotokun, Ighovwerha, et al.
  出版: (2016)
• 3159 Bone Turnover Biomarkers May Discriminate Low Bone Mineral Density in HIV-Infected Adults
  由: Collins, Lauren Frances, et al.
  出版: (2019)
• T cell RANKL/OPG imbalance is associated with HIV-induced bone loss in patients with higher CD4(+) T cell counts
  由: TITANJI, Kehmia, et al.
  出版: (2018)
• Dysregulated B Cell Expression of RANKL and OPG Correlates with Loss of Bone Mineral Density in HIV Infection
  由: Titanji, Kehmia, et al.
  出版: (2014)
• Immature/transitional B cell expansion is associated with bone loss in HIV-infected individuals with severe CD4(+) T cell lymphopenia
  由: TITANJI, Kehmia, et al.
  出版: (2020)